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We have reported previously that cyclic AMP-dependent protein kinase phosphorylates two sites on acetyl-CoA car- 
boxylase (site 1: Arg-Met-Ser(P)-Phe, and site 2: Ser-Ser(P)-Met-Ser-Gly-Leu), while the AMP-activated protein kinase 
also phosphorylates site 1, plus site 3 (Ser-Ser-Met-Ser(P)-Gly-Leu), the latter being two residues C-terminal to site 2. 
We now report that prior phosphorylation of site 2 by cyclic AMP-dependent protein kinase prevents the subsequent 
phosphorylation of site 3 and the consequent large decrease in V,,,,, produced by the AMP-activated protein kinase. Simi- 
larly, prior phosphorylation of site 3 by the AMP-activated protein kinase prevents subsequent phosphorylation of site 
2 by cyclic AMP-dependent protein kinase. 
Acetyl-CoA carboxylase; cyclic AMP-dependent protein kinase; AMP-activated protein kinase; Phosphorylation site; Interaction; (Rat) 
1. INTRODUCTION 
Acetyl-CoA carboxylase catalyses the first step 
committed to fatty acid biosynthesis, and is known 
to be regulated in vitro by allosteric effecters (e.g. 
activation by citrate) and by phosphorylation at 
multiple sites by a variety of protein kinases [ 1,2], 
including cyclic AMP-dependent protein kinase 
[3,4] and a protein kinase from rat liver which also 
phosphorylates HMG-CoA reductase, and which 
we have termed the AMP-activated protein kinase 
[5,6]. Recently we have defined by amino acid se- 
quencing the sites on acetyl-CoA carboxylase at 
which these two kinases inactivate the enzyme [7]. 
Phosphorylation by cyclic AMP-dependent pro- 
tein kinase produces an increase in K, for citrate 
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and a modest depression of V,,,,,, and is associated 
with the phosphorylation of sites 1 (Arg-Met- 
Ser(P)-Phe) and 2 (Ser-Ser(P)-Met-Ser-Gly-Leu). 
Phosphorylation by the AMP-activated protein 
kinase also increases the K, for citrate but pro- 
duces a much more dramatic decrease in V,,,,,, and 
this is associated with phosphorylation of site 1 
and site 3, the latter (Ser-Ser-Met-Ser(P)-Gly-Leu) 
being 2 residues C-terminal to site 2 [7]. Com- 
parison with the complete sequence of chicken 
acetyl-CoA carboxylase predicted from the recent- 
ly described cDNA sequence [8] shows that site 1 
is in the centre of the polypeptide (residue 1193), 
while sites 2 and 3 are close to the N-terminus 
(residues 78 and 80, respectively). 
The close proximity of sites 2 and 3 suggested 
the possibility that there may be interactions be- 
tween phosphorylation events at these sites. In this 
paper we report that phosphorylation of acetyl- 
CoA carboxylase by the cyclic AMP-dependent 
and AMP-activated protein kinases are not ad- 
ditive, and that phosphorylation at sites 2 and 3 
appear to be mutually exclusive. 
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2. MATERIALS AND METHODS 
2.1. Materials 
Acetyl-CoA carboxylase was purified from rat mammary 
gland and dephosphorylated with protein phosphatase-2A prior 
to use [7]. The catalytic subunit of cyclic AMP-dependent pro- 
tein kinase was purified from bovine heart [9]. The AMP- 
activated protein kinase (formerly called acetyl-CoA carbox- 
ylase kinase-3) was purified lOOO-fold from rat liver in the 
presence of 50 mM NaF and 5 mM Na pyrophosphate to a final 
specific activity of 50 units/mg as described in [6]. Sources of 
other radioisotopes and biochemicals were as described (71. 
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2.2. Methods 
Acetyl-CoA carboxylase (0.72 mg/ml) was phosphorylated at 
30°C in incubations containing AMP (100 FM), Na Hepes, pH 
7.0 (50 mM), glycerol (lo%, v/v), NaCl (50 mM), NaF 
(50 mM), EDTA (1 mM), dithiothreitol (1 mM), MgCla 
(4 mM) and [Y-~~P]ATP (0.2 mM, l-2 x lo5 cpm/nmol) and 
protein kinases as specified in the figure legends. Incorporation 
of phosphate into protein was measured by trichloroacetic acid 
precipitation [lo]. Acetyl-CoA carboxylase from these incuba- 
tions was also precipitated using ammonium sulphate to remove 
[y-32P]ATP, resuspended, and digested with proteinases as in 
[7]. Labelled peptides were separated by reverse-phase high- 
performance liquid chromatography (HPLC) in 0.1% (v/v) 
trifluoroacetic acid [7], dried in a centrifugal vacuum concen- 
trator, and analysed by thin layer isoelectric focussing [ll]. 
Parallel experiments were carried out using unlabelled ATP 
at the same concentration. Aliquots (10~1) were removed, 
diluted 50-fold in 0.1 I Tris-HCl, pH 7.4, and acetyl-CoA car- 
boxylase was assayed at 10 mM citrate as in [12]. 
3. RESULTS 
3.1. Sequential phosphorylation and inactivation 
by the two protein kinases 
Fig.1 shows that in the absence of added kinase 
there was no significant phosphorylation (A) or in- 
activation (B) of acetyl-CoA carboxylase during 
incubation for 60 min with MgATP. However in 
the presence of cyclic AMP-dependent protein 
kinase, there was incorporation of 1.4 mol 
phosphate per subunit (C), accompanied by a 
modest inactivation (-15%) of acetyl-CoA car- 
boxylase (D). The small effect on acetyl-CoA car- 
boxylase activity is due to the fact that the assays 
were performed using a near saturating citrate con- 
centration (10 mM), when only the small effect of 
cyclic AMP-dependent protein kinase on V,,,,, is 
observed [7]. Addition of the AMP-activated pro- 
tein kinase to the controls (A,B) after 60 min of in- 
cubation produced a large phosphorylation 
(1.5 mol/subunit) which correlated with a large in- 
activation (-7OOro), consistent with the known ef- 
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Fig. 1. Sequential phosphorylation of acetyl-CoA carboxylase 
by cyclic AMP-dependent protein kinase and the AMP- 
activated protein kinase. Acetyl-CoA carboxylase was 
incubated with [y-“P]ATP either with (open squares) or 
without (open circles) the catalytic subunit of cyclic AMP- 
dependent protein kinase (10 U/ml). After 60 min (arrow), the 
following additions were made: either AMP-activated protein 
kinase (filled symbols, 1 U/ml), a further identical aliquot of 
cyclic AMP-dependent protein kinase (open squares), or buffer 
only (open circles). At various times, aliquots were removed for 
determination of incorporation of phosphate into protein (A,C) 
or, from parallel incubations containing unlabelled ATP, for 
determination of acetyl-CoA carboxylase activity at 10 mM 
citrate (B,D). 
feet of this kinase on the V,,, of acetyl-CoA 
carboxylase [7]. By contrast, addition of the AMP- 
activated protein kinase after prior phosphoryla- 
tion by cyclic AMP-dependent protein kinase 
(C,D) produced only a slight additional 
phosphorylation (< 0.2 mol/subunit) and no addi- 
tional inactivation. 
Fig.2 shows data for the converse experiment. It 
is clear that prior phosphorylation by the AMP- 
activated protein kinase completely prevents addi- 
tional phosphorylation by cyclic AMP-dependent 
protein kinase. Phosphorylation by the AMP- 
activated protein kinase was associated with a large 
decrease in acetyl-CoA carboxylase activity similar 
to that shown in fig.lB: subsequent addition of 
cyclic AMP-dependent protein kinase produced no 
further inactivation (not shown). 
3.2. Analysis of phosphorylation sites 
Acetyl-CoA carboxylase that had been in- 
cubated with [Y-~~P]ATP and one protein kinase 
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Fig.2. Sequential phosphorylation of acetyl-CoA carboxylase 
by the AMP-activated protein kinase and cyclic AMP- 
dependent protein kinase. The experiment was identical with 
that in fig.lA,C except that the order of addition of the kinases 
was reversed. 
alone for 60 min, and enzyme that had been in- 
cubated with one kinase for 60 min and then the 
other kinase added for a further 60 min (as in figs 
1 and 2), was digested with trypsin alone, or with 
trypsin plus chymotrypsin, and the labelled pep- 
tides analysed by reverse-phase HPLC. The 
phosphopeptide profiles were very similar to those 
observed previously after treatment with in- 
dividual kinases [7]. After phosphorylation for 
60 min with cyclic AMP-dependent protein kinase 
or the AMP-activated protein kinase alone, the 
ratios of radioactivity obtained in tryp- 
tic/chymotryptic peptides TCl and TC2 were 0.96 
and 1.12, respectively. This is consistent with the 
fact that there is one site for each kinase on these 
peptides (TCl is Ser-Ser-Met-Ser-Gly-Leu, con- 
taining sites 2 and 3; TC2 is Arg-Met-Ser-Phe, con- 
taining site 1). If there was no interaction between 
sites 2 and 3, one would expect the ratio of 
radioactivity (TCl :TC2) to increase from 1: 1 to 
2: 1 as the additional site was filled by the second 
protein kinase. However, these ratios did not 
change significantly (1.00 and 0.82, respectively). 
Both kinases yielded one major tryptic peptide 
(Tl, corresponding to the peptide Ser-Ser-Met-Ser- 
Gly-Leu-His-Leu-Val-Lys [7]: site 1 is not 
recovered by HPLC after trypsin digestion) and 
labelling of Tl did not increase on incubation for 
a further 60 min in the presence of the second 
kinase (not shown). 
The failure of addition of a second kinase to in- 
crease labelling of TCl or Tl suggested that it was 
possible to label these peptides in site 2 or site 3, 
but not both. However, small amounts of 
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Fig.3. Thin layer isoelectric focussing of peptides Tl and TCl. 
Peptides were derived by digestion with trypsin (Tl) or 
trypsin + chymotrypsin (TCl), and partially purified by 
HPLC, from acetyl-CoA carboxylase that had been incubated 
with (lane 1) AMP-activated protein kinase for 60 min; (2) 
cyclic AMP-dependent protein kinase for 60 min; (3) AMP- 
activated protein kinase for 60 min, then cyclic AMP- 
dependent protein kinase for 60 min; (4) cyclic AMP-dependent 
protein kinase for 60 min, then AMP-activated protein kinase 
for 60 min (as described for figs 1 and 2). The photograph 
shows an autoradiogram of the dried gel. The approximate pl 
values were estimated using coloured protein isoelectric point 
markers (BDH Ltd., Poole, England). 
diphosphopeptides would not be readily detected 
in the presence of monophosphopeptides in our 
HPLC system, so we reanalysed the various forms 
of TCl and Tl by thin layer isoelectric focussing, 
in which different phosphorylated forms are 
dramatically separated [13]. Fig.3 shows that in 
every case TCl and Tl exhibited a single isoelectric 
point, ruling out the existence of even trace 
amounts of diphosphopeptides. 
4. DISCUSSION 
These data show unequivocally that site 2, 
phosphorylated by cyclic AMP-dependent protein 
kinase, and site 3, phosphorylated by the AMP- 
activated protein kinase, are mutually exclusive 
and cannot both be phosphorylated in the same 
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molecule of acetyl-CoA carboxylase, at least using 
these two protein kinases. The evidence may be 
summarised as follows: (i) prior phosphorylation 
by cyclic AMP-dependent protein kinase, which 
produces - 15% inactivation of acetyl-CoA car- 
boxylase measured at 10 mM citrate, completely 
prevented the large (-70%) inactivation that was 
produced by the AMP-activated protein kinase in 
a control preincubated in the absence of cyclic 
AMP-dependent protein kinase (cf. fig. IB and D). 
(ii) Phosphorylation by cyclic AMP-dependent 
protein kinase and the AMP-activated protein 
kinase was not additive (figs 1 and 2) and there was 
no increase in labelling of peptides containing sites 
2 and 3 (TCl or Tl) when acetyl-CoA carboxylase 
labelled with one kinase was incubated further 
with the second kinase. 
(iii) Isoelectric focussing gives no evidence that 
doubly phosphorylated forms of TCI or Tl were 
produced when acetyl-CoA carboxylase was in- 
cubated with both protein kinases (fig.3). TCI is a 
rather acidic peptide, and it is conceivable that a 
doubly phosphorylated form of TCI could have 
run off the end of the isofocussing gel and have 
been missed. However this is certainly not the case 
with Tl. 
It has been demonstrated using synthetic pep- 
tides [14] that basic residues (usually two adjacent 
arginines) on the N-terminal side of the 
phosphorylated serine are important specificity 
determinants for cyclic AMP-dependent protein 
kinase. Although comparable studies have not yet 
been carried out for the AMP-activated protein 
kinase, all sites so far sequenced ([7] and un- 
published) contain at least one arginine residue on 
the N-terminal side. Our results suggest that the in- 
troduction of a negatively charged phosphate 
group almost adjacent to the site of phosphoryla- 
tion is a negative specificity determinant for both 
protein kinases. 
Various types of positive and negative interac- 
tion between phosphorylation sites have been 
reported previously in other systems. For example, 
phosphorylation of glycogen synthase by casein 
kinase-2, which does not affect the kinetic proper- 
ties of the enzyme, creates a recognition site for 
phosphorylation by glycogen synthase kinase-3, 
which inactivates the enzyme [15]. On the other 
hand, phosphorylation of second and third serine 
residues on the Ela-subunit of pyruvate 
dehydrogenase by its specific kinase, inhibits 
dephosphorylation at the first, regulatory serine 
residue [ 161. 
Our results show that prior phosphorylation by 
cyclic AMP-dependent protein kinase prevents the 
larger inactivation normally produced by the 
AMP-activated protein kinase (fig. 1). This con- 
firms our previous suggestion [7] that it is site 3 
phosphorylation that is responsible for the large 
decrease in V,,,,, produced by the AMP-activated 
protein kinase. However this finding is at first 
sight paradoxical since cyclic AMP-elevating hor- 
mones inhibit fatty acid synthesis in hepatocytes 
and adipocytes [ 1,2]. Recent studies on sequencing 
of peptides TCl and Tl from isolated hepatocytes 
[17] have shown that site 3, but not site 2, is 
phosphorylated in basal hepatocytes, and that in- 
creased phosphorylation in response to the cyclic 
AMP-elevating hormone, glucagon, also occurs 
exclusively at site 3. The physiological significance 
of the effect of site 2 phosphorylation described in 
this paper is therefore unclear, at least for 
hepatocytes. 
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